Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake
about
Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to managementLifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trialsGenetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and SteatohepatitisPediatric fatty liver disease: role of ethnicity and geneticsThe Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.Physical activity and sedentary behavior can modulate the effect of the PNPLA3 variant on childhood NAFLD: a case-control study in a Chinese population.Understanding the pathophysiological mechanisms in the pediatric non-alcoholic fatty liver disease: The role of genetics.Pediatric non-alcoholic fatty liver disease: New insights and future directionsNonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming".The Association between Pediatric NAFLD and Common Genetic Variants.Commentary: dissecting the PNPLA3 association with liver fat and stiffness, and interaction with diet.Diet-Quality Scores and Prevalence of Nonalcoholic Fatty Liver Disease: A Population Study Using Proton-Magnetic Resonance SpectroscopyLinked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity.Calcium-independent phospholipases A2 and their roles in biological processes and diseases.Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis.Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review.PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.Major components of metabolic syndrome and nutritional intakes in different genotype of UCP2 -866G/A gene polymorphisms in patients with NAFLD.Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease.Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent.PNPLA3 I148M polymorphism and progressive liver disease.Estimation of fish and ω-3 fatty acid intake in pediatric nonalcoholic fatty liver disease.Oxidized fatty acids: A potential pathogenic link between fatty liver and type 2 diabetes in obese adolescents?The PNPLA3 Ile148Met interacts with overweight and dietary intakes on fasting triglyceride levelsType 2 diabetes mellitus in pediatrics: a new challenge.Genetic and epigenetic mechanisms of NASH.A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease.Pharmacogenomic and personalized approaches to tackle nonalcoholic fatty liver disease.TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children.PNPLA3 expression and its impact on the liver: current perspectives.Influence of dietary macronutrients on liver fat accumulation and metabolism.Role of diet and nutritional management in non-alcoholic fatty liver disease.Improved Diet Quality Associates With Reduction in Liver Fat-Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease.Metabolic Features of Nonalcoholic Fatty Liver (NAFL) in Obese Adolescents: Findings from a Multi-ethnic Cohort.PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease
P2860
Q26741557-6D758546-993B-4854-A6C5-173E7F9D7931Q26748608-04BCA810-62E1-49C3-9EA0-E81795B6C2C6Q26798151-386EFA32-6ED9-4C46-8662-84231DAC270AQ27026295-3C8E88F7-C784-4C39-8084-8CA2AFEC785EQ30382395-D71CB866-3B92-40E4-8CDA-0A0DA5004AAFQ30830629-2C169C14-2ED1-4225-B3F4-2C2779C0DCEBQ33360950-8EFE65FE-40CF-4D0D-9188-444A069435A6Q33563887-AD8E7711-AB2D-484B-AEF7-6B2DF143558AQ33580031-C5968C1B-E9BD-4C2A-BD29-74D17F736A63Q33831722-6E94B877-8231-4AD4-BA8B-83FC17ED030BQ33993581-1C50AC40-CB43-42B0-9AFC-D6C58A41B9A1Q35791636-EC92E7AB-3F8E-4A2D-9CFD-7B7685C0A85FQ35891405-BDE05C44-6383-4758-9291-0067D735FD43Q35894263-EE77F8FF-2E86-4627-ABCA-3B38A367EBDDQ35994344-F0A248CD-4786-43A7-A66F-219FEEE45958Q36083096-5AC1B2ED-519F-48C6-A410-C434FF467258Q36746574-09B20340-4138-405A-A04F-AE3C01DFD3F4Q36973400-7354875D-30B5-4435-900B-F7DE22D6C561Q37006682-3BC1D725-5D8C-4C33-B028-F5C213246F34Q37087800-08498F80-1B1C-4F3A-9CDE-3DB09B2203ACQ37197345-340C4B3B-C396-45F1-BCA2-72EA750A4072Q37285240-5427ED26-4308-4B5A-9C5E-D4352EEC2BB4Q37395638-A5F9C1EA-01B5-472A-B4DB-BFC05DD12114Q37460170-9C0B3B28-82C7-459A-820E-080E17F3459BQ37669834-C427B20F-CD67-4B7C-904B-3B2C6B6BB57AQ38162828-1B6177F7-17D2-455B-AD6B-B9A28532AAE6Q38673496-BC38941D-94DC-400C-89C8-47521A750032Q38675911-3A13DA5A-6A77-41A2-98C2-A42B409F2DAAQ38845334-FFC53919-9B8D-4402-B40B-31AE2D504DC1Q41040101-B6CED216-C077-4962-8BAD-72F8BCA4BCF7Q45414078-9A404E79-E027-4C94-AC2A-3DE60B64BEC9Q47744258-56D8B5CF-C6A9-4855-B91B-5712694E32BAQ50468162-19EABBFB-4840-4808-B0EB-937B48A1502CQ51731744-A87D9879-A3AF-41B3-B821-CC620B0CC73CQ52582972-F1332D1F-9CAD-4077-98D1-A975199BAFA3Q58773505-FB016872-4380-46E4-8344-D6873A31A349
P2860
Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Hepatic fat accumulation is mo ...... tary omega6/omega3 PUFA intake
@ast
Hepatic fat accumulation is mo ...... tary omega6/omega3 PUFA intake
@en
Hepatic fat accumulation is mo ...... tary omega6/omega3 PUFA intake
@nl
type
label
Hepatic fat accumulation is mo ...... tary omega6/omega3 PUFA intake
@ast
Hepatic fat accumulation is mo ...... tary omega6/omega3 PUFA intake
@en
Hepatic fat accumulation is mo ...... tary omega6/omega3 PUFA intake
@nl
prefLabel
Hepatic fat accumulation is mo ...... tary omega6/omega3 PUFA intake
@ast
Hepatic fat accumulation is mo ...... tary omega6/omega3 PUFA intake
@en
Hepatic fat accumulation is mo ...... tary omega6/omega3 PUFA intake
@nl
P2093
P2860
P1433
P1476
Hepatic fat accumulation is mo ...... tary omega6/omega3 PUFA intake
@en
P2093
Bridget Pierpont
Katie Marotto
Mary Savoye
Melissa M Shaw
P2860
P304
P356
10.1371/JOURNAL.PONE.0037827
P407
P577
2012-05-21T00:00:00Z